1. Home
  2. CLST vs RFL Comparison

CLST vs RFL Comparison

Compare CLST & RFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Catalyst Bancorp Inc.

CLST

Catalyst Bancorp Inc.

HOLD

Current Price

$16.42

Market Cap

66.9M

Sector

N/A

ML Signal

HOLD

Logo Rafael Holdings Inc. Class B

RFL

Rafael Holdings Inc. Class B

HOLD

Current Price

$1.31

Market Cap

61.1M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
CLST
RFL
Founded
1922
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
66.9M
61.1M
IPO Year
2021
2017

Fundamental Metrics

Financial Performance
Metric
CLST
RFL
Price
$16.42
$1.31
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
4.1K
103.5K
Earning Date
04-30-2026
03-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
28.28
EPS
0.43
N/A
Revenue
N/A
$917,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$38.16
N/A
Revenue Growth
N/A
43.96
52 Week Low
$10.67
$1.12
52 Week High
$16.98
$3.19

Technical Indicators

Market Signals
Indicator
CLST
RFL
Relative Strength Index (RSI) 55.84 52.39
Support Level $15.20 $1.35
Resistance Level $16.98 $1.38
Average True Range (ATR) 0.19 0.12
MACD -0.04 -0.01
Stochastic Oscillator 29.41 32.73

Price Performance

Historical Comparison
CLST
RFL

About CLST Catalyst Bancorp Inc.

Catalyst Bancorp Inc is a bank holding company. Through its subsidiary, which is a federally chartered community-oriented savings bank, it is engaged in attracting deposits from the general public and using those funds to invest in loans and securities. The sources of funds are customer deposits, repayments of loans, maturities of investments, and funds borrowed from outside sources, which are used for the origination of loans. It derives income principally from interest earned on loans and investment securities and, to a lesser extent, from fees received in connection with the origination of loans, service charges on deposit accounts, and other services.

About RFL Rafael Holdings Inc. Class B

Rafael Holdings Inc is a biotechnology firm that develops pharmaceuticals and invests in clinical and early-stage companies in pharmaceuticals and medical devices. Trappsol Cyclo is in Phase 3 trials for Niemann-Pick Disease Type C1. The company focuses on completing these trials, seeking regulatory approval, and commercializing the product. It also invests in portfolio companies including Cyclo, LipoMedix, Barer, Rafael Medical Devices, Cornerstone, and Day Three, targeting therapeutics for unmet medical needs. The business operates through three segments: Healthcare, Infusion Technology, and Real Estate. Operations are based in the United States and Israel.

Share on Social Networks: